Maravai Lifesciences Holdings (MRVI) Cash from Operations (2020 - 2026)

Maravai Lifesciences Holdings' Cash from Operations history runs 7 years deep, the most recent figure standing at 8665000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 192.28% year-over-year to 8665000.0; the TTM figure through Mar 2026 stood at 39518000.0 (down 704.07% YoY), while the FY2025 annual figure was 57573000.0, down 871.24% from the prior year.
• Cash from Operations was 8665000.0 for Q1 2026 at Maravai Lifesciences Holdings, up from 22768000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 164279000.0 in Q2 2022 to a low of 22768000.0 in Q4 2025.
• Historically, Cash from Operations has averaged 36515176.47 across 5 years, with a median of 13136000.0 in 2024.
• The sharpest annual moves came in 2022 and 2024: Cash from Operations surged 323.48% in 2022, then sank 287.91% in 2024.
• A 5-year view of Cash from Operations shows it stood at 99335000.0 in 2022, then sank by 92.16% to 7790000.0 in 2023, then tumbled by 287.91% to 14638000.0 in 2024, then sank by 55.54% to 22768000.0 in 2025, then soared by 138.06% to 8665000.0 in 2026.
• The last three Cash from Operations figures came in at 8665000.0 (Q1 2026), 22768000.0 (Q4 2025), and 15150000.0 (Q3 2025), per Business Quant data.